A fixed-dose combination supplement containing Taurine, a conditionally essential amino acid, and Acetylcysteine, a mucolytic agent and precursor to glutathione. This combination is primarily used in India as a hepatoprotective and antioxidant supplement, often for managing liver conditions, supporting detoxification, and providing antioxidant support in various metabolic and inflammatory states.
Adult: One tablet/capsule twice daily, or as directed by the physician. Typically taken after meals.
Note: Administer orally with a full glass of water, preferably after meals to minimize gastric upset. Do not crush or chew sustained-release formulations if any. For standard tablets/capsules, swallow whole.
The combination exerts synergistic hepatoprotective and antioxidant effects. Acetylcysteine serves as a precursor to L-cysteine, which is rate-limiting for the synthesis of glutathione, the body's primary intracellular antioxidant. It also acts as a direct antioxidant and mucolytic by breaking disulfide bonds in mucus. Taurine stabilizes cell membranes, regulates calcium homeostasis, acts as an osmoregulator, and has direct antioxidant and anti-inflammatory properties. Together, they combat oxidative stress, support Phase II liver detoxification, and protect hepatocytes from injury.
Pregnancy: Category B (US FDA). Animal studies show no risk, but human studies inadequate. Use only if potential benefit justifies potential risk to the fetus. Preferably avoid in first trimester.
Driving: Taurine may cause drowsiness or dizziness in some individuals. Patients should not drive or operate machinery until they know how the medication affects them.
| Nitroglycerin | Concomitant use may cause severe hypotension and headaches. | Major |
| Activated Charcoal | May adsorb oral Acetylcysteine and reduce its efficacy if administered simultaneously. | Moderate |
| Antihypertensive Drugs | Additive hypotensive effect possible with Taurine. | Moderate |
| CNS Depressants (Alcohol, Benzodiazepines) | Taurine may potentiate sedative effects. | Moderate |
| Chemotherapeutic agents (e.g., Doxorubicin) | Taurine may have protective effects against cardiotoxicity, potentially beneficial interaction. | Minor |
Same composition (Taurine (500mg) + Acetylcysteine (150mg)), different brands: